Change to the Method of Measuring Reportable Segment Profit
First written in FY2025-H1. 1 of 2 entries say "Restated". Latest entry: FY2025.
72 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「From the beginning of the current consolidated fiscal year, general and administrative expenses of certain consolidated subsidiaries that had previously been included in the Medical Business and Device Business segments have been included in general and administrative expenses not attributable to reportable segments, or corporate expenses, due to organizational expansion and other factors.」
The Group continues to disclose the change in the measurement method for reportable segment profit associated with organizational expansion, and compares the figures for the previous fiscal year after restating them using the revised method. - FY2025-H1First statedAnnual report
「From the beginning of the current interim consolidated accounting period, general and administrative expenses of certain consolidated subsidiaries that had previously been included in the Medical Business and Device Business segments have been included in general and administrative expenses not attributable to reportable segments, or corporate expenses, due to organizational expansion and other factors.」
Due to organizational expansion and other factors, general and administrative expenses of certain consolidated subsidiaries were changed from the respective reportable segments to corporate expenses. Segment information for the previous interim consolidated accounting period has been restated using the revised measurement method for comparison.